Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.

@article{Carrier2010SystematicRC,
  title={Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.},
  author={Marc Carrier and Gregoire Le Gal and Philip S Wells and Marc A Rodger},
  journal={Annals of internal medicine},
  year={2010},
  volume={152 9},
  pages={578-89}
}
The case-fatality rate is the proportion of patients who die of a particular condition. Venous thromboembolism (VTE), comprising deep venous thrombosis (DVT), pulmonary embolism, or both, can be fatal. Case-fatality rates of recurrent VTE and major bleeding events with anticoagulant therapy need to be taken into consideration when new anticoagulant strategies for patients with initial VTE are being assessed, and case-fatality rates of recurrent VTE without anticoagulation and major bleeding… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 138 extracted citations

Pulmonary embolism

Nature Reviews Disease Primers • 2018

References

Publications referenced by this paper.
Showing 1-10 of 83 references

Extended prophylaxis of venous thromboembolism with idraparinux.

The New England journal of medicine • 2007
View 12 Excerpts
Highly Influenced

Idraparinux versus standard therapy for venous thromboembolic disease.

The New England journal of medicine • 2007
View 11 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…